Conversely, in the presence of Val66Met mutation, pro-BDNF fails to be matured and secreted adequately, thereby disguising the miR-142-3p synaptotoxic effects of miR-142-3p on MS course which are likely, at least in part, dependent on BDNF inhibition. This evidence concerns the gene BDNF and myeloid sarcoma.